Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | TPMT | P51580 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13498580 | 1.00 | TNFRSF1A (0.47) | TNFRSF1AKMT2AMEN1CA12CA1 | |
| SCHEMBL26545271 | 1.00 | TNFRSF1A (0.47) | TNFRSF1AKMT2AMEN1CA12CA1 | |
| SCHEMBL30036849 | 0.88 | KMT2A (0.46) | KMT2AMEN1ALDH1A1PTK2BPOLB | |
| SCHEMBL30036048 | 0.88 | KMT2A (0.46) | KMT2AMEN1ALDH1A1PTK2BPOLB | |
| SCHEMBL30037023 | 0.88 | KMT2A (0.46) | KMT2AMEN1ALDH1A1PTK2BPOLB | |
| SCHEMBL16072742 | 0.87 | RARB (0.46) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL16333870 | 0.87 | TNFRSF1A (0.47) | TNFRSF1AKMT2AMEN1ALDH1A1PTK2B | |
| SCHEMBL26545606 | 0.86 | KMT2A (0.50) | KMT2AMEN1ALDH1A1PTK2B | |
| SCHEMBL23558403 | 0.86 | TNFRSF1A (0.46) | TNFRSF1AKMT2AMEN1ALDH1A1PTK2B | |
| SCHEMBL797245 | 0.86 | KMT2A (0.48) | TNFRSF1AKMT2AMEN1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2026-02-03 | — | — | US | disclosed |
| US-20240400898-A1 | TEMPERATURE PROGRAMMABLE SMALL MOLECULES FOR THERMORESPONSIVE SMART WINDOWS AND APPLICATIONS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2024-12-05 | — | — | US | disclosed |
| EP-4347550-A1 | ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS | The Trustees of the University of Pennsylvania (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022251191-A1 | ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-12-01 | — | — | WO | disclosed |
| US-9623046-B2 | Amphiphilic Janus-dendrimers | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-04-18 | — | — | US | disclosed |
| US-8404216-B2 | Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-03-26 | — | — | US | disclosed |
| US-8404216-B2 | Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-03-26 | — | — | US | disclosed |
| US-20120308640-A1 | AMPHIPHILIC JANUS-DENDRIMERS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2012-12-06 | — | — | US | disclosed |
| US-20110021626-A1 | ENCAPSULATION OF VITAMIN C INTO WATER SOLUBLE DENDRIMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2011-01-27 | — | — | US | disclosed |
| US-20110021626-A1 | ENCAPSULATION OF VITAMIN C INTO WATER SOLUBLE DENDRIMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2011-01-27 | — | — | US | disclosed |
| US-20100104512-A1 | Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-04-29 | — | — | US | disclosed |
| US-20100104512-A1 | Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-04-29 | — | — | US | disclosed |
| WO-2008043911-A2 | DENDRITIC CHELATED COMPOUNDS, METHODS FOR MAKING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120308640-A1 | AMPHIPHILIC JANUS-DENDRIMERS | OR10J3, H1-10, CXCR3 | TNFRSF1A 2551/4885KMT2A 2299/4885MEN1 755/4885 |
| US-20110021626-A1 | ENCAPSULATION OF VITAMIN C INTO WATER SOLUBLE DENDRIMERS | PROC, CD44, CCNC | TNFRSF1A 2718/4885KMT2A 3398/4885MEN1 1722/4885 |
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | CRY1, C1S, CRY2 | TNFRSF1A 369/4885KMT2A 715/4885MEN1 2168/4885 |
| US-20100104512-A1 | Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same | ZYX, CXCR4, ZFX | TNFRSF1A 2213/4885KMT2A 3370/4885MEN1 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.